流通市值:25.55亿 | 总市值:25.55亿 | ||
流通股本:1.77亿 | 总股本:1.77亿 |
报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 27,349,157.18 | 43,755,523.49 | 19,011,948.01 | 7,403,249.62 |
应收票据及应收账款 | 5,617,097.08 | 2,761,902.19 | 9,439,520.74 | 3,513,922.03 |
其中:应收票据 | - | 50,640 | - | - |
应收账款 | 5,617,097.08 | 2,711,262.19 | 9,439,520.74 | 3,513,922.03 |
预付款项 | 1,946,781.08 | 1,507,102.57 | 2,903,426.71 | 6,927,858.45 |
其他应收款合计 | 32,637,130.88 | 31,726,485.04 | 32,110,261.19 | 30,931,913.93 |
存货 | 164,323,929.3 | 169,858,131.35 | 182,677,720.37 | 183,751,881.9 |
其他流动资产 | 488,464.93 | 846,944.91 | 876,694.02 | 808,503.5 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 232,362,560.45 | 250,456,089.55 | 247,019,571.04 | 233,337,329.43 |
非流动资产: | ||||
其他权益工具投资 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
固定资产 | 81,927,034.32 | 83,596,550.83 | 83,666,626.68 | 85,426,227.99 |
生产性生物资产 | 8,079,072.32 | 8,774,795.39 | 8,485,869.1 | 9,181,592.17 |
使用权资产 | 337,992.75 | 337,992.75 | 876,694.02 | 876,694.02 |
无形资产 | 142,651,385.16 | 144,512,635.86 | 143,135,581.32 | 144,984,209.68 |
长期待摊费用 | 1,424,253.25 | 1,444,100.36 | 1,481,551.55 | 1,584,643.65 |
递延所得税资产 | 143,130.57 | 143,130.57 | 505,080.77 | 505,080.77 |
其他非流动资产 | - | - | - | 0 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 235,562,868.37 | 239,809,205.76 | 239,151,403.44 | 243,558,448.28 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 467,925,428.82 | 490,265,295.31 | 486,170,974.48 | 476,895,777.71 |
流动负债: | ||||
短期借款 | 5,000,000 | 5,000,000 | 5,000,000 | - |
应付票据及应付账款 | 54,245,467.43 | 57,606,325.54 | 81,371,650.87 | 87,569,140.43 |
应付账款 | 54,245,467.43 | 57,606,325.54 | 81,371,650.87 | 87,569,140.43 |
预收款项 | 851,113.2 | 30,773.7 | 737,170.85 | 1,135,440.55 |
合同负债 | 927,386.73 | 4,857,021.55 | 2,806,372.68 | 3,497,238.76 |
应付职工薪酬 | 11,123,981.99 | 11,804,815.03 | 13,151,978.45 | 16,044,784.33 |
应交税费 | 56,443,730.53 | 66,263,146.11 | 68,315,520.5 | 60,432,646.2 |
其他应付款合计 | 132,390,616.81 | 140,902,305.88 | 117,227,724.33 | 114,420,879.18 |
其中:应付利息 | 3,615,175.73 | 3,537,948.33 | 4,517,182.72 | 4,438,239.15 |
一年内到期的非流动负债 | 50,000,000 | 50,000,000 | 684,212.81 | 684,212.81 |
其他流动负债 | 21,394.12 | 587,310.36 | 248,896.48 | 331,152.84 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 311,003,690.81 | 337,051,698.17 | 289,543,526.97 | 284,115,495.1 |
非流动负债: | ||||
长期借款 | - | - | 50,000,000 | 50,000,000 |
预计负债 | - | - | - | 23,042,276.04 |
递延所得税负债 | 33,700.56 | 33,700.56 | 223,580.92 | 223,580.92 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 33,700.56 | 33,700.56 | 50,223,580.92 | 73,265,856.96 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 311,037,391.37 | 337,085,398.73 | 339,767,107.89 | 357,381,352.06 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 177,408,000 | 177,408,000 | 177,408,000 | 177,408,000 |
资本公积 | 558,928,709.21 | 558,659,669.21 | 557,054,994.39 | 556,573,662.27 |
盈余公积 | 5,861,319.98 | 5,861,319.98 | 5,861,319.98 | 5,861,319.98 |
未分配利润 | -586,455,534.96 | -589,892,880.94 | -594,967,575.03 | -621,565,902.48 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 155,742,494.23 | 152,036,108.25 | 145,356,739.34 | 118,277,079.77 |
少数股东权益 | 1,145,543.22 | 1,143,788.33 | 1,047,127.25 | 1,237,345.88 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 156,888,037.45 | 153,179,896.58 | 146,403,866.59 | 119,514,425.65 |
负债和股东权益合计 | 467,925,428.82 | 490,265,295.31 | 486,170,974.48 | 476,895,777.71 |
公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-31 |
审计意见(境内) | 标准无保留意见 |